Edit |   |
---|---|
Antigenic Specificity | SARS-CoV-2 Spike Glycoprotein (Sotrovimab biosimilar) |
Clone | Sotrovimab (VIR-7831/GSK4182136) |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | Human IgG |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-SARS-CoV-2 Spike Glycoprotein Recombinant Antibody. Sotrovimab is an investigational monoclonal antibody therapy medication with activity against SARS-CoV-2. It is under development by GlaxoSmithKline and Vir Biotechnology, Inc. |
Immunogen | n/a |
Other Names | Anti-Spike Glycoprotein Recombinant Antibody, Research Grade Sotrovimab (VIR-7831/GSK4182136), Anti-SARS-CoV-2 Spike Glycoprotein Recombinant Antibody, VIR-7831, GSK4182136, Antibody Drug Analogues, Monoclonal Antibody, YR1642, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | n/a |
Catalog # | YR1642 |
Price | please inquire |
Order / More Info | SARS-CoV-2 Spike Glycoprotein (Sotrovimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |